Furthermore, FOXA1 transgenic mouse models developed in this study provide a valuable bioresource for studying the pathobiology of breast, salivary gland, and bladder tumors, which harbor recurrent FOXA1 alterations. This evidence concerns the gene FOXA1 and urinary bladder neoplasm.